WallStreetZenWallStreetZen

NASDAQ: SPRO
Spero Therapeutics Inc Stock Ownership - Who owns Spero Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Spero Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Sath ShuklaCEO and President2024-02-0545,093$1.45
$65.38kSell
Ankit MahadeviaDirector2024-02-0263,795$1.37
$87.40kSell
Kamal HamedChief Medical Officer2024-02-0228,075$1.37
$38.46kSell
Tamara L. JosephChief Legal Officer2024-02-0230,906$1.37
$42.34kSell
Sath ShuklaCEO and President2024-02-0230,901$1.37
$42.33kSell
Timothy KeutzerChief Operating Officer2024-02-0230,971$1.36
$42.12kSell
Kamal HamedChief Medical Officer2023-09-1339,496$1.27
$50.16kSell
Sath ShuklaCEO and President2023-08-294,163$1.30
$5.41kSell
Ankit MahadeviaDirector2023-08-289,040$1.26
$11.39kSell
Sath ShuklaCEO and President2023-08-281,854$1.26
$2.34kSell

1 of 2

SPRO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SPRO insiders and whales buy or sell their stock.

SPRO Shareholders

What type of owners hold Spero Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Aquilo Capital Management LLC21.55%11,606,674$16.66MInsider
Gsk PLC17.06%9,190,606$13.19MInsider
Anson Funds Management LP7.98%4,297,699$6.17MInstitution
Glaxosmithkline PLC7.03%3,788,012$5.44MInsider
Jean Francois Formela4.47%2,408,128$3.46MInsider
Vikas Goyal3.44%1,854,006$2.66MInsider
Vanguard Group Inc3.05%1,643,757$2.36MInstitution
Sath Shukla2.18%1,176,007$1.69MInsider
Casper Breum2.03%1,091,774$1.57MInsider
Adar1 Capital Management LLC1.98%1,067,711$1.53MInstitution

1 of 3

SPRO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SPRO25.60%64.13%Net SellingNet Selling
TPST4.15%95.85%
VTVT0.11%99.89%Net BuyingNet Buying
ATHA57.11%31.41%Net Buying
CNTB12.92%0.00%
View Top Biotech Stocks

Spero Therapeutics Stock Ownership FAQ

Who owns Spero Therapeutics?

Spero Therapeutics (NASDAQ: SPRO) is owned by 25.60% institutional shareholders, 64.13% Spero Therapeutics insiders, and 10.27% retail investors. Aquilo Capital Management LLC is the largest individual Spero Therapeutics shareholder, owning 11.61M shares representing 21.55% of the company. Aquilo Capital Management LLC's Spero Therapeutics shares are currently valued at $16.48M.

If you're new to stock investing, here's how to buy Spero Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.